Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of remimazolam toluenesulfonate for loss of consciousness in female gynecologic surgery patients
ChiCTR2100052835Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in endometrial polyp, sponsored by Weifang People's Hospital. Primary endpoints: Heart rate, Response to command for eye opening and 3 more. Started Nov 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
endometrial polyp
Beyond the preview
Go deeper on ChiCTR2100052835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052835.